Alector Correlations
| ALEC Stock | USD 1.38 0.07 4.83% |
The current 90-days correlation between Alector and Black Diamond Therapeutics is 0.37 (i.e., Weak diversification). The correlation of Alector is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Alector Correlation With Market
Weak diversification
The correlation between Alector and DJI is 0.3 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Alector and DJI in the same portfolio, assuming nothing else is changed.
Alector |
Moving together with Alector Stock
| 0.75 | ME | 23Andme Holding | PairCorr |
| 0.62 | DSGN | Design Therapeutics | PairCorr |
| 0.84 | VKTX | Viking Therapeutics | PairCorr |
| 0.79 | VRCA | Verrica Pharmaceuticals | PairCorr |
| 0.83 | VTYX | Ventyx Biosciences | PairCorr |
Moving against Alector Stock
| 0.56 | VALN | Valneva SE ADR Earnings Call Today | PairCorr |
| 0.54 | DVAX | Dynavax Technologies | PairCorr |
| 0.71 | VRNA | Verona Pharma PLC Buyout Trend | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Alector Stock performing well and Alector Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Alector's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| PASG | 3.91 | (0.73) | 0.00 | (0.58) | 0.00 | 7.02 | 56.48 | |||
| BDTX | 3.81 | (0.21) | 0.00 | (0.20) | 0.00 | 5.92 | 29.04 | |||
| TCRR | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| HARP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| RVMD | 1.72 | (0.16) | 0.00 | (0.23) | 0.00 | 4.37 | 11.35 | |||
| BCEL | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| STOK | 3.46 | (0.38) | 0.00 | (0.31) | 0.00 | 7.03 | 20.29 | |||
| FIXX | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| GLUE | 3.62 | (0.41) | 0.00 | (0.40) | 0.00 | 7.34 | 19.92 | |||
| CABA | 4.20 | (0.16) | 0.00 | (0.21) | 0.00 | 9.46 | 26.78 |
Alector Corporate Management
| Virginia MBA | Chief Strategy | Profile | |
| Norah Conway | Program Portfolio | Profile | |
| Gary MD | Chief Officer | Profile | |
| Katie Hogan | Senior Relations | Profile |